Cytokine release assays have emerged as a crucial tool for evaluating the safety and efficacy of potential therapeutics. At Creative Biolabs, we are proud to offer an expanded suite of cytokine release assays designed to provide comprehensive insights into the functionality of tumor-infiltrating lymphocytes (TILs).
Tumor-infiltrating lymphocytes (TILs) are immune cells that have entered the tumor microenvironment, playing a crucial role in the immune response to tumors. Assessing cytokine release from these lymphocytes is essential for advancing our understanding of tumor immunity. As a leader in immunotherapy, Creative Biolabs offers cutting-edge services to support your research on TIL cytokine release assays. Our comprehensive suite of assays includes intracellular cytokine release assays, ELISA, and ELISPOT, delivering accurate and reliable cytokine measurements. Our team of experts customizes these assays to the unique requirements of each project, providing high-quality data to drive breakthrough discoveries.
Broad Panel of Cytokines
Our service includes the measurement of a comprehensive panel of cytokines such as IL-2, IL-6, TNF-alpha, and IFN-gamma, among others. This extensive coverage ensures that all critical markers of immune activation are monitored.
Comprehensive Technologies
Utilizing state-of-the-art technologies like flow cytometry, ELISA, and ELISPOT, we ensure high sensitivity and specificity in cytokine detection, providing robust data that informs decision-making processes.
Creative Biolabs strives to lead in the field of cytokine release assays by offering highly specialized services characterized by innovation, reliability, and precision. Whether you are developing novel TIL therapies or seeking to understand immune dynamics better, our team of experienced scientists is here to support your project needs. Explore our services today and contact us in the quest to unlock the full potential of TIL therapy in the fight against cancer.
For any technical issues or product/service related questions, please leave your information below. Our team will contact you soon.
All products and services are For Research Use Only and CANNOT be used in the treatment or diagnosis of disease.
NEWSLETTER
The latest newsletter to introduce the latest breaking information, our site updates, field and other scientific news, important events, and insights from industry leaders
LEARN MORE NEWSLETTER
NEW SOLUTION
CellRapeutics™ In Vivo Cell Engineering: One-stop in vivo T/B/NK cell and macrophage engineering services covering vectors construction to function verification.
LEARN MORE SOLUTION
NOVEL TECHNOLOGY
Silence™ CAR-T Cell: A novel platform to enhance CAR-T cell immunotherapy by combining RNAi technology to suppress genes that may impede CAR functionality.
LEARN MORE NOVEL TECHNOLOGY
NEW SOLUTION
Canine CAR-T Therapy Development: From early target discovery, CAR design and construction, cell culture, and transfection, to in vitro and in vivo function validation.
LEARN MORE SOLUTION